65. Primary immunodeficiency Clinical trials / Disease details


Clinical trials : 500 Drugs : 614 - (DrugBank : 119) / Drug target genes : 92 - Drug target pathways : 217

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05462587
(ClinicalTrials.gov)
July 28, 202228/6/2022A Study to Evaluate Efficacy and Safety of AVTX-803 in Patients With Leukocyte Adhesion Deficiency Type IIA Phase 3, Randomized, Double-blind, Two-period, Crossover, Withdrawal Study to Assess the Efficacy and Safety of AVTX-803 in Subjects With Leukocyte Adhesion Deficiency Type II (LAD II)Leukocyte Adhesion DeficiencyDrug: AVTX-803 (L-Fucose)Avalo Therapeutics, Inc.NULLRecruiting6 Months75 YearsAll4Phase 3United States
2NCT03354533
(ClinicalTrials.gov)
January 1, 201221/11/2017Study of ORL-1F (L-fucose) in Patients With Leukocyte Adhesion Deficiency Type IIStudy of ORL-1F (L-fucose) in Patients With Leukocyte Adhesion Deficiency Type IILeukocyte Adhesion Deficiency, Type IIDrug: L-fucoseOrpha LabsNULLCompletedN/A18 YearsAll4Phase 1/Phase 2NULL